Abstract
  • Population : Immunocompetent individuals living in JE-endemic areas
  • Intervention: One dose of live recombinant JE vaccine
  • Comparison: Placebo/no vaccination/other JE vaccine
  • Outcome : JE disease (immunogenicity accepted)
  • GRADE table
  • Japanese encephalitis